Integrated BioPharma Reports Results for its Quarter Ended December 31, 2019
HILLSIDE, NJ / ACCESSWIRE / February 12, 2020 / Integrated BioPharma, Inc. (OTC BB:INBP) (the…
Staff
Hepion Pharmaceuticals Announces Advancement to Third Dose Level in Ongoing Multiple Ascending Dose Clinical Study of CRV431
EDISON, NJ / ACCESSWIRE / February 12, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical…
World’s First Bedside MRI System Receives FDA 510(k) Clearance
Novel MRI system is a breakthrough in patient accessibility and cost GUILFORD, Conn.–(BUSINESS WIRE)–Hyperfine Research,…
Milestone Scientific Receives Notice of Allowance for European Patent Related to Peripheral Nerve Block Instrument
LIVINGSTON, NJ / ACCESSWIRE / February 12, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a developer…
Voycare Fast Tracks Development of Medical Second Opinion Online Portal Confirming Entry into China’s $100B Telemedicine Industry
COVINA, CA / ACCESSWIRE / February 12, 2020 / North America Frac Sand, Inc. dba…
AIM ImmunoTech’s CEO to Appear Live Today on FOX Business Network’s The Claman Countdown and Cheddar’s Opening Bell to Discuss the Potential Role of Ampligen(R) for Use Against the Wuhan 2019 Novel Coronavirus
OCALA, FL / ACCESSWIRE / February 12, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM), an immuno-pharma…
Dr. Mak Jawadekar Joins the Board of Directors of NanoViricides, Inc.
SHELTON, CT / ACCESSWIRE / February 12, 2020 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”),…
Memorial Sloan Kettering Cancer Center Extends Allscripts Sunrise™ Agreement
CHICAGO–(BUSINESS WIRE)–#healthIT–Allscripts Healthcare Solutions (NASDAQ: MDRX) today announced that Memorial Sloan Kettering Cancer Center (MSK),…
PEI-Genesis, TE Connectivity Expand Partnership: Company Adds Industrial Unit to Current AD&M Solutions
PHILADELPHIA–(BUSINESS WIRE)–#PEIGenesis—PEI-Genesis, a global leader in the design and assembly of custom engineered connectors and…
AiCuris collaborates with myTomorrows to initiate an Early Access Program for Pritelivir
AiCuris collaborates with myTomorrows to initiate an Early Access Program for Pritelivir The Early Access…